STABLE PROTEIN AND NUCLEIC ACID FORMULATIONS, USING NON-AQUEUS, ANHYDROUS, APROTIC, HYDROPHOBIC, NON-POLAR VEHICLES WITH LOW REACTIVITY

THIS INVENTION RELATES TO STABLE NON-AQUEOUS FORMULATIONS WHICH ARE SUSPENSIONS OF PROTEINACEOUS SUBSTANCES OR NUCLEIC ACIDS IN NON-AQUEOUS, ANHYDROUS, APROTIC, HYDROPHOBIC, NON-POLAR VEHICLES WITH LOW REACTIVITY. MORE SPECIFICALLY , THE PRESENT INVENTION RELATES TO STABLE PROTEIN OR NUCLEIC ACID FO...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JESSICA G. SMITH, MANLEY T.F. HUANG, STEVEN J. PRESTRELSKI, VICTORIA MARIE KNEPP
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator JESSICA G. SMITH
MANLEY T.F. HUANG
STEVEN J. PRESTRELSKI
VICTORIA MARIE KNEPP
description THIS INVENTION RELATES TO STABLE NON-AQUEOUS FORMULATIONS WHICH ARE SUSPENSIONS OF PROTEINACEOUS SUBSTANCES OR NUCLEIC ACIDS IN NON-AQUEOUS, ANHYDROUS, APROTIC, HYDROPHOBIC, NON-POLAR VEHICLES WITH LOW REACTIVITY. MORE SPECIFICALLY , THE PRESENT INVENTION RELATES TO STABLE PROTEIN OR NUCLEIC ACID FORMULATIONS WHEREIN THE COMPOUND REMAINS INSTABLE, DRY POWDER FORM, YET THE FORMULATION IS FLOWABLE AND, THEREFORE AMENABLE TO DELIVERY TO AN ANIMAL VIA INJECTION, TRANSDERMAL ADMINISTRATION, ORAL DELIVERY OR USING AN IMPLANTABLE DEVICE FOR SUSTAINED DELIVERY. THESE STABLE FORMULATIONS MAY BE STORED AT ELEVATED TEMPERATURES (E.G., 37°C ) FOR LONG PERIODS OF TIME AND ARE ESPECIALLY USEFUL AS FLOWABLE FORMULATIONS WHICH CAN BE SHIPPED AND/OR STORED AT HIGH TEMPERATURES OR IN IMPLANTABLE DELIVERY DEVICES FOR LONG TERM DELIVERY (E.G., 1-12 MONTHS OR LONGER) OF DRUG.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MY125597A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MY125597A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MY125597A3</originalsourceid><addsrcrecordid>eNqFjM0KgkAUhd20iOoV4j6ALiokWl7Hsbkwzdj8KK5EYlpFCfYOvXYq7Vudcz4-zjL6WIeZ5FAa7TgpQJWD8kxyYoCMcii0uXiJjrSyMXhL6gxKqwSvnvuRoBJNbvRcpxNiMcykFDqbxiSXWqKBigsany3U5ARIXYPhyBxV5Jp1tLh3jyFsfrmKtgV3TCShf7Vh6LtbeIZ3e2l2-zQ9HfHwV_gCsU49JQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>STABLE PROTEIN AND NUCLEIC ACID FORMULATIONS, USING NON-AQUEUS, ANHYDROUS, APROTIC, HYDROPHOBIC, NON-POLAR VEHICLES WITH LOW REACTIVITY</title><source>esp@cenet</source><creator>JESSICA G. SMITH ; MANLEY T.F. HUANG ; STEVEN J. PRESTRELSKI ; VICTORIA MARIE KNEPP</creator><creatorcontrib>JESSICA G. SMITH ; MANLEY T.F. HUANG ; STEVEN J. PRESTRELSKI ; VICTORIA MARIE KNEPP</creatorcontrib><description>THIS INVENTION RELATES TO STABLE NON-AQUEOUS FORMULATIONS WHICH ARE SUSPENSIONS OF PROTEINACEOUS SUBSTANCES OR NUCLEIC ACIDS IN NON-AQUEOUS, ANHYDROUS, APROTIC, HYDROPHOBIC, NON-POLAR VEHICLES WITH LOW REACTIVITY. MORE SPECIFICALLY , THE PRESENT INVENTION RELATES TO STABLE PROTEIN OR NUCLEIC ACID FORMULATIONS WHEREIN THE COMPOUND REMAINS INSTABLE, DRY POWDER FORM, YET THE FORMULATION IS FLOWABLE AND, THEREFORE AMENABLE TO DELIVERY TO AN ANIMAL VIA INJECTION, TRANSDERMAL ADMINISTRATION, ORAL DELIVERY OR USING AN IMPLANTABLE DEVICE FOR SUSTAINED DELIVERY. THESE STABLE FORMULATIONS MAY BE STORED AT ELEVATED TEMPERATURES (E.G., 37°C ) FOR LONG PERIODS OF TIME AND ARE ESPECIALLY USEFUL AS FLOWABLE FORMULATIONS WHICH CAN BE SHIPPED AND/OR STORED AT HIGH TEMPERATURES OR IN IMPLANTABLE DELIVERY DEVICES FOR LONG TERM DELIVERY (E.G., 1-12 MONTHS OR LONGER) OF DRUG.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20060830&amp;DB=EPODOC&amp;CC=MY&amp;NR=125597A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20060830&amp;DB=EPODOC&amp;CC=MY&amp;NR=125597A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JESSICA G. SMITH</creatorcontrib><creatorcontrib>MANLEY T.F. HUANG</creatorcontrib><creatorcontrib>STEVEN J. PRESTRELSKI</creatorcontrib><creatorcontrib>VICTORIA MARIE KNEPP</creatorcontrib><title>STABLE PROTEIN AND NUCLEIC ACID FORMULATIONS, USING NON-AQUEUS, ANHYDROUS, APROTIC, HYDROPHOBIC, NON-POLAR VEHICLES WITH LOW REACTIVITY</title><description>THIS INVENTION RELATES TO STABLE NON-AQUEOUS FORMULATIONS WHICH ARE SUSPENSIONS OF PROTEINACEOUS SUBSTANCES OR NUCLEIC ACIDS IN NON-AQUEOUS, ANHYDROUS, APROTIC, HYDROPHOBIC, NON-POLAR VEHICLES WITH LOW REACTIVITY. MORE SPECIFICALLY , THE PRESENT INVENTION RELATES TO STABLE PROTEIN OR NUCLEIC ACID FORMULATIONS WHEREIN THE COMPOUND REMAINS INSTABLE, DRY POWDER FORM, YET THE FORMULATION IS FLOWABLE AND, THEREFORE AMENABLE TO DELIVERY TO AN ANIMAL VIA INJECTION, TRANSDERMAL ADMINISTRATION, ORAL DELIVERY OR USING AN IMPLANTABLE DEVICE FOR SUSTAINED DELIVERY. THESE STABLE FORMULATIONS MAY BE STORED AT ELEVATED TEMPERATURES (E.G., 37°C ) FOR LONG PERIODS OF TIME AND ARE ESPECIALLY USEFUL AS FLOWABLE FORMULATIONS WHICH CAN BE SHIPPED AND/OR STORED AT HIGH TEMPERATURES OR IN IMPLANTABLE DELIVERY DEVICES FOR LONG TERM DELIVERY (E.G., 1-12 MONTHS OR LONGER) OF DRUG.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjM0KgkAUhd20iOoV4j6ALiokWl7Hsbkwzdj8KK5EYlpFCfYOvXYq7Vudcz4-zjL6WIeZ5FAa7TgpQJWD8kxyYoCMcii0uXiJjrSyMXhL6gxKqwSvnvuRoBJNbvRcpxNiMcykFDqbxiSXWqKBigsany3U5ARIXYPhyBxV5Jp1tLh3jyFsfrmKtgV3TCShf7Vh6LtbeIZ3e2l2-zQ9HfHwV_gCsU49JQ</recordid><startdate>20060830</startdate><enddate>20060830</enddate><creator>JESSICA G. SMITH</creator><creator>MANLEY T.F. HUANG</creator><creator>STEVEN J. PRESTRELSKI</creator><creator>VICTORIA MARIE KNEPP</creator><scope>EVB</scope></search><sort><creationdate>20060830</creationdate><title>STABLE PROTEIN AND NUCLEIC ACID FORMULATIONS, USING NON-AQUEUS, ANHYDROUS, APROTIC, HYDROPHOBIC, NON-POLAR VEHICLES WITH LOW REACTIVITY</title><author>JESSICA G. SMITH ; MANLEY T.F. HUANG ; STEVEN J. PRESTRELSKI ; VICTORIA MARIE KNEPP</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MY125597A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2006</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>JESSICA G. SMITH</creatorcontrib><creatorcontrib>MANLEY T.F. HUANG</creatorcontrib><creatorcontrib>STEVEN J. PRESTRELSKI</creatorcontrib><creatorcontrib>VICTORIA MARIE KNEPP</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JESSICA G. SMITH</au><au>MANLEY T.F. HUANG</au><au>STEVEN J. PRESTRELSKI</au><au>VICTORIA MARIE KNEPP</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>STABLE PROTEIN AND NUCLEIC ACID FORMULATIONS, USING NON-AQUEUS, ANHYDROUS, APROTIC, HYDROPHOBIC, NON-POLAR VEHICLES WITH LOW REACTIVITY</title><date>2006-08-30</date><risdate>2006</risdate><abstract>THIS INVENTION RELATES TO STABLE NON-AQUEOUS FORMULATIONS WHICH ARE SUSPENSIONS OF PROTEINACEOUS SUBSTANCES OR NUCLEIC ACIDS IN NON-AQUEOUS, ANHYDROUS, APROTIC, HYDROPHOBIC, NON-POLAR VEHICLES WITH LOW REACTIVITY. MORE SPECIFICALLY , THE PRESENT INVENTION RELATES TO STABLE PROTEIN OR NUCLEIC ACID FORMULATIONS WHEREIN THE COMPOUND REMAINS INSTABLE, DRY POWDER FORM, YET THE FORMULATION IS FLOWABLE AND, THEREFORE AMENABLE TO DELIVERY TO AN ANIMAL VIA INJECTION, TRANSDERMAL ADMINISTRATION, ORAL DELIVERY OR USING AN IMPLANTABLE DEVICE FOR SUSTAINED DELIVERY. THESE STABLE FORMULATIONS MAY BE STORED AT ELEVATED TEMPERATURES (E.G., 37°C ) FOR LONG PERIODS OF TIME AND ARE ESPECIALLY USEFUL AS FLOWABLE FORMULATIONS WHICH CAN BE SHIPPED AND/OR STORED AT HIGH TEMPERATURES OR IN IMPLANTABLE DELIVERY DEVICES FOR LONG TERM DELIVERY (E.G., 1-12 MONTHS OR LONGER) OF DRUG.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_MY125597A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title STABLE PROTEIN AND NUCLEIC ACID FORMULATIONS, USING NON-AQUEUS, ANHYDROUS, APROTIC, HYDROPHOBIC, NON-POLAR VEHICLES WITH LOW REACTIVITY
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T05%3A38%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JESSICA%20G.%20SMITH&rft.date=2006-08-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMY125597A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true